DNA sequencing improves cancer treatment but remains underused. Why?

Despite guidelines and the common use of genetic sequencing for cancer patients at major medical centers, experts say many patients are missing out.

Related Keywords

Dana Farber Cancer Institute ,Massachusetts ,United States ,Georgia ,Arkansas ,Stanford University ,California ,Chicago ,Illinois ,Northwestern University ,Michigan ,Americans ,American ,William Catalona ,Paul Boutros ,Marie Suga ,Stephen Gruber ,Kaiser Permanente ,Thomas Roberts ,Allison Kurian ,Steven Katz ,Matthew Meyerson ,Joe Biden ,American Society Of Clinical Oncology ,David Geffen School Of Medicine ,Cancer Center ,Astrazeneca ,Kaiser Permanente National Lung Cancer Program ,University Of Michigan Dr ,Stanford Cancer Institute ,Mass General Cancer ,American Society ,Clinical Oncology ,Center For Precision Medicine ,National Lung Cancer ,David Geffen School ,